The Role of Automation and AI in High-Mix Low-Volume Manufacturing

The medical manufacturing industry is defined by constant innovation and high-level competition. As quality and delivery standards continue to rise each year, high-mix/low-volume manufacturers must adopt new technologies to stay ahead of the curve. Since 2023, Arcamed’s investments in automation and AI have reduced costs by 25% while maintaining consistent order completion rates. Automation has established consistent procedures, allowing 8-week lead times at 98.8% on time delivery, 97.7% on time in full, and 97.7% orders defect-free. This has enabled Arcamed to cultivate a reputation as an industry leader in speed, quality, and cost. This presentation will explore the strategic investments in technology that have enabled a greater state of control and visibility of capacity, supply chain, and delivery, offering practical insights into the successful navigation and implementation of new technology.

Attend this presentation by Arcamed in Booth 1160.